Robeco Institutional Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $55.3M | Sell |
610,991
-114,434
| -16% | -$9.59M | 0.07% | 253 |
|
|
2026
Q1 | $58.1M | Buy |
725,425
+61,238
| +9% | +$5.05M | 0.08% | 235 |
|
|
2025
Q4 | $56.6M | Sell |
664,187
-62,269
| -9% | -$5.11M | 0.08% | 227 |
|
|
2025
Q3 | $56.5M | Sell |
726,456
-16,853
| -2% | -$1.32M | 0.08% | 224 |
|
|
2025
Q2 | $58.1M | Sell |
743,309
-5,594
| -0.7% | -$417K | 0.09% | 206 |
|
|
2025
Q1 | $54.3M | Buy |
748,903
+474,492
| +173% | +$34M | 0.11% | 182 |
|
|
2024
Q4 | $20.3M | Sell |
274,411
-30,176
| -10% | -$2.11M | 0.04% | 328 |
|
|
2024
Q3 | $20.1M | Sell |
304,587
-59,936
| -16% | -$4.35M | 0.04% | 332 |
|
|
2024
Q2 | $33.7M | Sell |
364,523
-19,977
| -5% | -$1.77M | 0.07% | 242 |
|
|
2024
Q1 | $36.7M | Buy |
384,500
+19,558
| +5% | +$1.64M | 0.08% | 240 |
|
|
2023
Q4 | $27.8M | Sell |
364,942
-189,400
| -34% | -$13.2M | 0.07% | 275 |
|
|
2023
Q3 | $38.4M | Buy |
554,342
+12,449
| +2% | +$1M | 0.1% | 211 |
|
|
2023
Q2 | $51.1M | Buy |
541,893
+7,535
| +1% | +$655K | 0.13% | 177 |
|
|
2023
Q1 | $44.2M | Sell |
534,358
-9,488
| -2% | -$746K | 0.12% | 189 |
|
|
2022
Q4 | $40.6M | Sell |
543,846
-224,015
| -29% | -$17.3M | 0.12% | 196 |
|
|
2022
Q3 | $63.4M | Buy |
767,861
+23,390
| +3% | +$2.25M | 0.21% | 109 |
|
|
2022
Q2 | $70.8M | Buy |
744,471
+25,616
| +4% | +$2.65M | 0.22% | 112 |
|
|
2022
Q1 | $84.6M | Buy |
718,855
+12,080
| +2% | +$1.36M | 0.2% | 121 |
|
|
2021
Q4 | $91.6M | Sell |
706,775
-2,686
| -0.4% | -$313K | 0.19% | 121 |
|
|
2021
Q3 | $80.3M | Buy |
709,461
+108,902
| +18% | +$12.4M | 0.18% | 136 |
|
|
2021
Q2 | $62.2M | Buy |
600,559
+21,382
| +4% | +$2.02M | 0.14% | 168 |
|
|
2021
Q1 | $48.4M | Buy |
579,177
+4,086
| +0.7% | +$345K | 0.12% | 204 |
|
|
2020
Q4 | $52.5M | Sell |
575,091
-155,294
| -21% | -$12.9M | 0.14% | 180 |
|
|
2020
Q3 | $58.3M | Sell |
730,385
-111,838
| -13% | -$8.73M | 0.18% | 138 |
|
|
2020
Q2 | $58.2M | Buy |
842,223
+98,067
| +13% | +$6.97M | 0.2% | 128 |
|
|
2020
Q1 | $46.8M | Buy |
744,156
+30,801
| +4% | +$2.22M | 0.19% | 138 |
|
|
2019
Q4 | $55.5M | Buy |
713,355
+326,061
| +84% | +$25.5M | 0.18% | 158 |
|
|
2019
Q3 | $28.4M | Sell |
387,294
-164,028
| -30% | -$11.5M | 0.1% | 258 |
|
|
2019
Q2 | $34M | Buy |
551,322
+153,594
| +39% | +$9.29M | 0.12% | 234 |
|
|
2019
Q1 | $25.4M | Buy |
397,728
+26,259
| +7% | +$1.5M | 0.09% | 297 |
|
|
2018
Q4 | $19M | Sell |
371,469
-34,587
| -9% | -$1.75M | 0.09% | 295 |
|
|
2018
Q3 | $23.6M | Buy |
406,056
+55,911
| +16% | +$2.73M | 0.09% | 267 |
|
|
2018
Q2 | $17M | Buy |
350,145
+11,598
| +3% | +$541K | 0.08% | 306 |
|
|
2018
Q1 | $15.7M | Sell |
338,547
-22,236
| -6% | -$966K | 0.07% | 310 |
|
|
2017
Q4 | $13.6M | Buy |
360,783
+28,128
| +8% | +$1.03M | 0.07% | 306 |
|
|
2017
Q3 | $12.1M | Buy |
332,655
+317,199
| +2,052% | +$12.1M | 0.08% | 270 |
|
|
2017
Q2 | $609K | Sell |
15,456
-105
| -0.7% | -$3.83K | ﹤0.01% | 719 |
|
|
2017
Q1 | $488K | Sell |
15,561
-105,726
| -87% | -$3.31M | ﹤0.01% | 727 |
|
|
2016
Q4 | $3.79M | Sell |
121,287
-78,699
| -39% | -$2.55M | 0.03% | 411 |
|
|
2016
Q3 | $8.04M | Sell |
199,986
-6,738
| -3% | -$254K | 0.06% | 298 |
|
|
2016
Q2 | $6.87M | Buy |
206,724
+6,480
| +3% | +$222K | 0.05% | 310 |
|
|
2016
Q1 | $5.89M | Buy |
200,244
+49,749
| +33% | +$1.37M | 0.05% | 335 |
|
|
2015
Q4 | $3.96M | Sell |
150,495
-54,693
| -27% | -$1.42M | 0.03% | 374 |
|
|
2015
Q3 | $4.86M | Hold |
205,188
| – | – | 0.04% | 345 |
|
|
2015
Q2 | $4.87M | Sell |
205,188
-15,108
| -7% | -$341K | 0.04% | 352 |
|
|
2015
Q1 | $5.23M | Buy |
220,296
+15,600
| +8% | +$350K | 0.04% | 348 |
|
|
2014
Q4 | $4.35M | Buy |
204,696
+124,326
| +155% | +$2.5M | 0.03% | 349 |
|
|
2014
Q3 | $1.37M | Buy |
80,370
+74,490
| +1,267% | +$1.18M | 0.01% | 517 |
|
|
2014
Q2 | $84K | Buy |
+5,880
| New | +$79.7K | ﹤0.01% | 716 |
|
|
2013
Q4 | – | Sell |
-4,218
| Closed | -$49K | – | 693 |
|
|
2013
Q3 | $49K | Hold |
4,218
| – | – | ﹤0.01% | 635 |
|
|
2013
Q2 | $47K | Buy |
+4,218
| New | +$49.9K | ﹤0.01% | 610 |
|
Other funds holding EW
WT
Robeco Institutional Asset Management's EW Position: Q2 2026 in Review
Robeco Institutional Asset Management reduced its Edwards Lifesciences (EW) stake by 16% in Q2 2026, selling an estimated $9.59M and leaving 610,991 shares worth $55.3M. The position accounts for 0.07% of the portfolio, ranked #253.
Robeco Institutional Asset Management first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $91.6M in Q4 2021. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Robeco Institutional Asset Management held 610,991 shares of Edwards Lifesciences worth $55.3M as of Q2 2026.
- Robeco Institutional Asset Management sold 114,434 Edwards Lifesciences shares in Q2 2026, an estimated $9.59M.
- Edwards Lifesciences made up 0.07% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #253 holding.
- Robeco Institutional Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- Robeco Institutional Asset Management's Edwards Lifesciences position peaked at $91.6M in Q4 2021.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.